SCHEMBL13596222

SCHEMBL13596222

CC(O)C(O)c1c(OCC2CC2)ccc2c(CCC3CCN(c4ccc(Cl)nn4)CC3)noc12

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
BCHE P06276 2/20 0.33
PANK3 Q9H999 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4133377 0.90 ACHE (0.37) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4124618 0.84 ACHE (0.41) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4124614 0.82 ACHE (0.39) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4120913 0.82 ACHE (0.39) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4112904 0.82 ACHE (0.39) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4112912 0.82 ACHE (0.39) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4125743 0.82 ACHE (0.39) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4127857 0.78 MEN1 (0.35) ACHEMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4121348 0.71 ACHE (0.41) ACHEBCHE
SCHEMBL4130389 0.71 ACHE (0.39) ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 ACHE 3716/4885MEN1 1361/4885KMT2A 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.